Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combination (Q43177478)
Jump to navigation
Jump to search
scientific article published on 2 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combination |
scientific article published on 2 February 2010 |
Statements
1 reference
Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combination (English)
1 reference
Pierre Mordant
1 reference
Yohann Loriot
1 reference
Céline Leteur
1 reference
Julien Calderaro
1 reference
Jean Bourhis
1 reference
Marie Wislez
1 reference
Eric Deutsch
1 reference
2 February 2010
1 reference
1 reference
Identifiers
1 reference